Calendar

NOT_YET_RECRUITINGphase readoutNCT07557511: Transcutaneous Electrical Nerve Stimulation Versus Repetitive Transcranial Magnetic Stimulation on Pain and Functional Outcome in Cervical Radiculopathy

Sponsor: Cairo University. Phase: NA. Conditions: Cervical Radiculopathy

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04530565: Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07540507: Data Collection of the TUVA BX and iCover Stent Grafts Implanted During Branched Endovascular Aortic Repair (BEVAR)

Sponsor: JOTEC GmbH. Phase: . Conditions: TAAA, AAA - Abdominal Aortic Aneurysm

full page →ctgov ↗

COMPLETEDphase readoutNCT07512492: Combination Effect of Proprioceptive Training and Transcranial Magnetic Stimulation on Selected Gait Kinematic Parameters in Stroke Patients

Sponsor: Cairo University. Phase: NA. Conditions: Transcranial Magnetic Stimulation, Stroke, Gait Disorders, Neurologic, Proprioceptive Training

full page →ctgov ↗

COMPLETEDphase readoutNCT07502092: Mindfulness in Motion Targeted to Sustaining the Mental and Physical Resilience of First Responders

Sponsor: Ohio State University. Phase: NA. Conditions: Stress, Resilience and Mental Health of First Responders, Work Engagement, Musculoskeletal Discomfort, First Responders

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07533292: Bacteriophage Therapy for Orthopedic Implant-Associated Infections

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE3. Conditions: Orthopedic, Implant Infection

full page →ctgov ↗

RECRUITINGphase readoutNCT04732065: ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Sponsor: Sabine Mueller, MD, PhD. Phase: PHASE1. Conditions: Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma, Recurrent Malignant Central Nervous System Neoplasm, Spinal Cord Glioma, World Health Organization (WHO) Grade III Glioma, CNS Tumor, Central Nervous System Tumor

full page →ctgov ↗

COMPLETEDphase readoutNCT02652767: Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation

Sponsor: GenSight Biologics. Phase: PHASE3. Conditions: Optic, Atrophy, Hereditary, Leber

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07606807: rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: PHASE3. Conditions: Acute Ischemic Stroke

full page →ctgov ↗

RECRUITINGphase readoutNCT06543407: Harm Reduction for Smokers With Mental Illness

Sponsor: Dartmouth-Hitchcock Medical Center. Phase: NA. Conditions: Tobacco Dependence

full page →ctgov ↗

RECRUITINGphase readoutNCT05698992: Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer

Sponsor: Region Skane. Phase: . Conditions: Esophageal Cancer, Esophageal Neoplasms, Gastric Cancer, Stomach Neoplasm

full page →ctgov ↗

RECRUITINGphase readoutNCT02838836: Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

Sponsor: University of Missouri-Columbia. Phase: . Conditions: Non-small Cell Lung Cancer, Esophageal Cancer, Gastric Cancer, Pancreatic Cancer, Hepatocellular Cancer, Colorectal Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03317392: Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07309536: Mediterranean Diet Uptake and Nutrition on Child Health, Inflammation, and Early-life Symbiosis (MUNCHIES) Study

Sponsor: University of New Brunswick. Phase: NA. Conditions: Gut Microbiome, Body Composition, Adherence, Metabolites, Inflammation

full page →ctgov ↗

RECRUITINGphase readoutNCT06818136: Bladder EpiCheck European Haematuria Study

Sponsor: Nucleix Ltd.. Phase: . Conditions: Hematuria, Cystoscopy, Urothelial Carcinoma Bladder, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma of the Urinary Bladder

full page →ctgov ↗

COMPLETEDphase readoutNCT07307911: Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy

Sponsor: Damanhour University. Phase: PHASE2. Conditions: Breast Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07551011: Impact of Behavioural Modification Working Toolkit Among Women With Gestational Diabetes Mellitus and Hypertension

Sponsor: University of the Punjab. Phase: NA. Conditions: Gestational Diabetes Mellitus in Pregnancy, Hypertension ,Pregnancy

full page →ctgov ↗

COMPLETEDphase readoutNCT07449611: Comparative Impacts of Two Anesthesia Methods on Peripheral Tissue Oxygenation in the Upper Limb

Sponsor: Sakarya University. Phase: NA. Conditions: Regional Anesthesia, Interscalene Blocks, Shoulder Surgery, Perfusion Index

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT02522611: Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: PHASE1. Conditions: Intractable Pain, Palliative Care

full page →ctgov ↗

RECRUITINGphase readoutNCT07207707: A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

Sponsor: Kumquat Biosciences Inc.. Phase: PHASE1. Conditions: Solid Tumor Malignancies

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06114992: Servo-n HFOV Study: Safety and Performance in Neonates and Infants

Sponsor: Maquet Critical Care AB. Phase: . Conditions: Elective HFOV for Respiratory Failure in Neonates/Infants, Rescue HFOV in Neonates and/Infants With Refractory Respiratory Failure Under Conventional Therapy

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07330492: Testing a Brief Reassurance Message Before a Musculoskeletal Clinic Visit

Sponsor: University of Texas at Austin. Phase: NA. Conditions: Any Non-traumatic Musculoskeletal Condition

full page →ctgov ↗

TERMINATEDphase readoutNCT04396236: A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Migraine

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04927650: Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening

Sponsor: University of California, San Francisco. Phase: . Conditions: Cervical Carcinoma, Human Papillomavirus-Related Carcinoma

full page →ctgov ↗

COMPLETEDphase readoutNCT06502574: Self-Care Management in Older Adults

Sponsor: Sultan Ayaz Alkaya. Phase: NA. Conditions: Disease Self Management

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07591974: Simulation-Based Training on Immediate Newborn Care

Sponsor: University of Baghdad. Phase: NA. Conditions: Newborn Care

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07300891: T Cell Inflamed Gene Expression Profiling Score-guided Anti PD-1 Therapy (Tislelizumab Monotherapy) for Refractory Solid Cancer Patients Unexposed to Immunotherapy

Sponsor: Samsung Medical Center. Phase: PHASE2. Conditions: Refractory Solid Cancer Patients Unexposed to Immunotherapy

full page →ctgov ↗

RECRUITINGphase readoutNCT07037511: Effects of Salbutamol in Athletes and Implications for Screening and Sports

Sponsor: University of British Columbia. Phase: NA. Conditions: Asthma, Healthy, Effect of Drug

full page →ctgov ↗

RECRUITINGphase readoutNCT07314411: Carotenoid Supplementation and Retinal Health in Healthy Adults

Sponsor: Pacific University. Phase: NA. Conditions: Healthy

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04401111: One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: . Conditions: COVID, ARDS, Quality of Life

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06247111: Monitoring Blood Pressure at Home

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Hypertension

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07512011: Outcomes of Different Bone Graft Combinations for Maxillary Sinus Augmentation Procedure

Sponsor: Ohio State University. Phase: . Conditions: Bone Grafting, Sinus Lifting

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07606092: Human Tendon Tissue Collection

Sponsor: Queen Mary University of London. Phase: . Conditions: Tendinopathy, Musculoskeletal Diseases or Conditions, ACL Surgery, Achilles Tendon Surgery

full page →ctgov ↗

RECRUITINGphase readoutNCT05947136: PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.

Sponsor: Centre Leon Berard. Phase: NA. Conditions: Multiple Myeloma, Complication

full page →ctgov ↗

RECRUITINGphase readoutNCT06326411: A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Sponsor: Nested Therapeutics, Inc. Phase: PHASE1. Conditions: Oncology, MEK Mutation, RAF Gene Mutation, Ras (KRAS or NRAS) Gene Mutation, Melanoma, NSCLC, Glioma, Solid Tumor, Adult, MAPK Pathway Gene Mutation

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04554914: A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Sponsor: Pierre Fabre Medicament. Phase: PHASE2. Conditions: Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD), EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant, Stem Cell Transplant Complications, EBV+ Sarcomas, Leiomyosarcoma

full page →ctgov ↗

RECRUITINGphase readoutNCT02986516: Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease

Sponsor: Italian Sarcoma Group. Phase: NA. Conditions: Chordoma

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07485816: A Study on the Correlation Between Cardiac-Cerebral Oxygenation Reserve and Cognitive Function Changes in Heart Failure Patients

Sponsor: Yan'an Affiliated Hospital of Kunming Medical University. Phase: . Conditions: Heart Failure (HF)

full page →ctgov ↗

RECRUITINGphase readoutNCT07585916: Prenatal Yoga Intervention in Pregnant Women

Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Pregnant Women, Prenatal Yoga, Trauma, Body Image, Delivery

full page →ctgov ↗

RECRUITINGphase readoutNCT03611816: Biological Bank for Atrial Fibrillation and Stroke

Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Stroke, Atrial Fibrillation

full page →ctgov ↗

RECRUITINGphase readoutNCT06630416: Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors

Sponsor: Northwestern University. Phase: PHASE2. Conditions: Metastatic Bladder Urothelial Carcinoma, Metastatic Malignant Solid Neoplasm, Stage IV Bladder Cancer AJCC v8

full page →ctgov ↗

COMPLETEDphase readoutNCT03548506: Subthalamic Steering for Therapy Optimization in Parkinson's Disease

Sponsor: University Hospital Tuebingen. Phase: NA. Conditions: Parkinson Disease

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT01946204: A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer

Sponsor: Aragon Pharmaceuticals, Inc.. Phase: PHASE3. Conditions: Prostatic Neoplasms

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05454852: Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in Zambia

Sponsor: Boston University. Phase: . Conditions: HIV

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07282652: A Study to Evaluate the Safety and Tolerability of RAG-18 in Pediatric Patients With Duchenne Muscular Dystrophy

Sponsor: Peking Union Medical College Hospital. Phase: EARLY_PHASE1. Conditions: Duchenne Muscular Dystrophy (DMD)

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT06718049: Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juvenile Idiopathic Arthritis and Autoinflammatory Diseases: Possible Biomarkers in the Differential Diagnosis of Other Febrile Diseases

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna. Phase: . Conditions: Systemic Juvenile Idiopathic Arthritis (sJIA)

full page →ctgov ↗

COMPLETEDphase readoutNCT06952049: Does Psychoeducation Improve the Pain Relief Derived From a Brief Intervention

Sponsor: Florida State University. Phase: NA. Conditions: Pain, Acute Pain

full page →ctgov ↗

RECRUITINGphase readoutNCT07557849: Multicentric Database for KRAS Mutant Pancreatic Cancer

Sponsor: Fudan University. Phase: . Conditions: Pancreatic Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT07618338: Virtual Reality-Based Smoking Cessation Treatment in Patients With Schizophrenia

Sponsor: Dokuz Eylul University. Phase: NA. Conditions: Schizophrenia Disorder

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03767348: Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

Sponsor: Replimune, Inc.. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma

full page →ctgov ↗

Date TBD